- Ownership hops held
- 56
An absent edge means not yet observed — never does not exist.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. — US company (sec:0001650648). UBO chain traced 56 hops, 18 owners. Every claim linked to its source.
Ownership resolves 56 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- 4D Molecular Therapeutics, Inc.
None in current sources.
56-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on 4D Molecular Therapeutics, Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
33 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- BIOTECHNOLOGY VALUE FUND II LPAlso holds roles at 40 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- BIOTECHNOLOGY VALUE FUND L PAlso holds roles at 41 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- Biotechnology Value Trading Fund OS LPAlso holds roles at 37 other companies
- XOMA Royalty Corpdirector
- Olema Pharmaceuticals, Inc.director
- XOMA Royalty Corpother
- BVF GP HOLDINGS LLCAlso holds roles at 42 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- XOMA Royalty Corptenpercentowner
- BVF I GP LLCAlso holds roles at 39 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.director
- BVF II GP LLCAlso holds roles at 38 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.other
- BVF INC/ILAlso holds roles at 44 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- ADVANCED MAGNETICS INCtenpercentownerother
- BVF PARTNERS L P/ILAlso holds roles at 46 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- ADVANCED MAGNETICS INCtenpercentownerother
- BVF Partners OS Ltd.Also holds roles at 37 other companies
- XOMA Royalty Corpdirector
- Olema Pharmaceuticals, Inc.director
- Olema Pharmaceuticals, Inc.other
- Chacko JacobAlso holds roles at 2 other companies
- Oric Pharmaceuticals, Inc.officer
- Oric Pharmaceuticals, Inc.director
- GRAY SUSANNAHAlso holds roles at 5 other companies
- ANAPTYSBIO, INCdirector
- MARAVAI LIFESCIENCES HOLDINGS, INC.director
- Theravance Biopharma, Inc.director
- HALVORSEN OLE ANDREASAlso holds roles at 16 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Humer KristianAlso holds roles at 3 other companies
- Foghorn Therapeutics Inc.officer
- Sensei Biotherapeutics, Inc.director
- Viridian Therapeutics, Inc.\DEofficer
- Kolchinsky PeterAlso holds roles at 88 other companies
- Mineralys Therapeutics, Inc.director
- Janux Therapeutics, Inc.10% owner
- Solid Biosciences Inc.10% owner
- LAMPERT MARK NAlso holds roles at 42 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.director
- Mehra UneekAlso holds roles at 3 other companies
- Helix Acquisition Corp. IIother
- Helix Acquisition Corp. IIofficer
- MYOVANT SCIENCES LTD.officer
- MILLER-RICH NANCYAlso holds roles at 3 other companies
- Aldeyra Therapeutics, Inc.director
- INTERCEPT PHARMACEUTICALS INCdirector
- KADMON HOLDINGS, INC.director
- MILLIGAN JOHN FAlso holds roles at 3 other companies
- GILEAD SCIENCES, INC.officer
- KAILERA THERAPEUTICS, INC.director
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.director
- MORETTI AUGUST JAlso holds roles at 3 other companies
- ALEXZA PHARMACEUTICALS INC.officer
- Vivani Medical, Inc.director
- Cibus, Inc.director
- Ott David C.Also holds roles at 16 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- RA Capital Healthcare Fund LPAlso holds roles at 83 other companies
- Mineralys Therapeutics, Inc.director
- Janux Therapeutics, Inc.10% owner
- Solid Biosciences Inc.10% owner
- RA CAPITAL MANAGEMENT, L.P.Also holds roles at 86 other companies
- Mineralys Therapeutics, Inc.director
- Janux Therapeutics, Inc.10% owner
- Solid Biosciences Inc.10% owner
- SBLENDORIO GLENNAlso holds roles at 6 other companies
- Mineralys Therapeutics, Inc.director
- MEDICINES CO /DEofficer
- AMICUS THERAPEUTICS, INC.director
- Shabet Rose SharonAlso holds roles at 16 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Shah Rajeev M.Also holds roles at 85 other companies
- Mineralys Therapeutics, Inc.director
- Janux Therapeutics, Inc.10% owner
- Solid Biosciences Inc.10% owner
- THEUER CHARLESAlso holds roles at 3 other companies
- GTX INC /DE/director
- TRACON PHARMACEUTICALS INCdirector
- TRACON PHARMACEUTICALS INCofficer
- TOMASELLO SHAWNAlso holds roles at 5 other companies
- Cabaletta Bio, Inc.director
- Kalaris Therapeutics, Inc.director
- GAMIDA CELL LTD.director
- VIKING GLOBAL INVESTORS LPAlso holds roles at 16 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Viking Global Opportunities GP LLCAlso holds roles at 16 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Viking Global Opportunities Illiquid Investments Sub-Master LPAlso holds roles at 16 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Viking Global Opportunities Parent GP LLCAlso holds roles at 15 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Viking Global Opportunities Portfolio GP LLCAlso holds roles at 16 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
33 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns 4D Molecular Therapeutics, Inc.?
- What is 4D Molecular Therapeutics, Inc.'s risk level?
- Where does 4D Molecular Therapeutics, Inc. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for 4D Molecular Therapeutics, Inc. — nothing is disclosed before that.